Biodexa Pharmaceuticals PLC (BDRX)

5.30 -0.17 (-3.05%) USD  |  NASDAQ  |  Nov 08, 16:00
5.30 0.00 (0.00%) After-Hours: 20:00
More

Biodexa Pharmaceuticals Research and Development Expense (% of Annual Revenues)

Research and Development Expense (% of Annual Revenues) Chart

View Research and Development Expense (% of Annual Revenues) for BDRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Research and Development Expense (% of Annual Revenues) Data

View and export this data back to . Upgrade now.
Date Value

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (% of Annual Revenues) Range, Past 5 Years

--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (% of Annual Revenues) Benchmarks

Adaptimmune Therapeutics PLC Upgrade
Verona Pharma PLC --
NuCana PLC --
Autolus Therapeutics PLC Upgrade
TC BioPharm (Holdings) PLC --